TransCode Therapeutics Reports 2022 Results; Provides Business Update
Go back to TransCode Therapeutics Reports 2022 Results; Provides Business Update| (NASDAQ: RNAZ) | Delayed: 1.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.76 | 52 Week High | $ | |||
| Open | $1.76 | 52 Week Low | $ | |||
| Day High | $1.76 | P/E | N/A | |||
| Day Low | $1.76 | EPS | $ | |||
| Volume | 3,701 | |||||
